A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
Clinical trial NCT03669640 · TERMINATED
Trial details
- NCT number
- NCT03669640
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-04
- Primary completion
- 2023-03-12
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.